Nyxoah Announces Partnership with ResMed in Germany

Nyxoah Announces Partnership with ResMed in Germany
Creates a continuum of care in the German obstructive sleep apnea market

Mont-Saint-Guibert, Belgium – September 28, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has entered into a partnership with ResMed Germany to increase OSA awareness and therapy penetration in the German market.

Nyxoah and ResMed Germany will establish a continuum of care that will educate and guide OSA patients in the German market from diagnosis through treatment. Together, the companies will work to accelerate patient identification and better support patient set-up on the appropriate therapy. The companies will collaborate on:

  • OSA helplines and direct-to-consumer marketing initiatives
  • Sales and marketing efforts targeting ENTs and sleep physicians
  • Patient and clinician educational programs and symposiums

“We are thrilled to partner with ResMed Germany, as it strengthens further our patient-first approach to treating obstructive sleep apnea. OSA reduces quality of life and can result in other serious medical conditions, such as cardiovascular disease, and type 2 diabetes. Together, ResMed Germany and Nyxoah will heighten awareness of OSA and increase therapy penetration,” commented Olivier Taelman, Nyxoah’s Chief Executive Officer. “The OSA ecosystem created by this partnership will guide patients from diagnosis to the right treatment for them, whether that is a mandibular device, continuous positive airway pressure (CPAP), or hypoglossal nerve stimulation (HGNS).”

“It is our joint goal to enable more patients to receive effective, personalized therapy,” said Katrin Pucknat, President, ResMed Germany. “Over 95 percent of patients in Germany suffering from sleep apnea are not diagnosed or treated. In addition, there are patients who have problems with their therapy and just stop it without considering an alternative. The partnership with Nyxoah will enable us to broaden the education around therapy options and empower patients to benefit from improved health outcomes.”

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward-looking statements
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2022, filed with the Securities and Exchange Commission (“SEC”) on March 22, 2023, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Attachment

GlobeNewswire Distribution ID 1000841557

Introducing the Icomera X7 Mobile Connectivity & Applications Router

Supercharged 5G Connectivity for Onboard Systems and Passengers

Gothenburg, Sweden, Sept. 28, 2023 (GLOBE NEWSWIRE) — Icomera’s new X7 router is a gateway to a powerful centralised connectivity platform, supporting multiple, resource-intensive applications including Passenger Wi-Fi, Onboard Infotainment, and Digital Video Surveillance & Analytics. A wholly owned subsidiary of Equans, global leader in the energy and services industry, Icomera is the leading provider of integrated connectivity solutions for public transport and contributes to a low carbon and resilient world by making public transport more attractive. 

“Nowadays, a plethora of onboard systems installed on vehicles require ubiquitous, reliable connectivity”, explains Roger Matthews, Icomera’s Chief Commercial Officer. “The X7 delivers exceptional speed, storage and performance for both operational and passenger-focused services, ushering in a new era of cutting-edge connected applications.”

The X7 utilises SureWAN™, Icomera’s industry-leading connectivity technology protocol for intelligently aggregating multiple communication technologies (5G, 4G, satellite, trackside networks etc.) in parallel, to ensure the fastest, most reliable connection available to a moving vehicle. Network traffic can be monitored and managed using IcoShape, Icomera’s data traffic shaping tool, empowering transport operators to make best use of all available Internet bandwidth and control their data costs.

“One or multiple X7 units can be installed on a single vehicle or train consist”, adds Mats Karlsson, Icomera’s Chief Technology Officer and Co-founder. “By distributing network traffic between two routers, load balancing helps ensure optimised performance, while redundancy adds further resiliency to an onboard connectivity solution.”

The X7 router will be available in various models at launch, each optimised to meet specific business requirements:

  • For digital video surveillance deployments, in addition to providing real-time data offload, the X7 can be configured with up to two externally accessible SSDs. This is useful when the physical storage and/or removal of video surveillance footage is a requirement, and reduces the need for an external Network Attached Storage (NAS) device. In many cases, the 32TB (2 x 16TB) SSDs allow transport operators to store up to a month’s worth of video footage.
  • Some X7 models contain up to two built-in dual band Wi-Fi 6 cards, each capable of operating as an access point to provide high-quality passenger Wi-Fi.
  • The X7 contains up to five 5G modems for industry-leading connectivity.

Details of the X7 follow Icomera’s announcement of the world’s first Wi-Fi 7 access point purpose-built for public transportation – the Icomera A2. By leveraging the increased throughput and reduced latency that Wi-Fi 7 offers, the new access point will facilitate faster and more reliable web browsing, streaming, downloads, and video conferencing for passengers, allowing them to stay connected more effortlessly while they travel.

Attachments

Tom Bates
Icomera
tom.bates@icomera.com

GlobeNewswire Distribution ID 8930233

New global study discovers people in pain feel more socially excluded than ever

  • Latest edition of Haleon Pain Index finds half (49%) of people in pain feel stigmatised[1][2]
  • 42% regularly feel lonely due to their pain, and one third feel serious loneliness (based on UCLA loneliness scale)[3]
  • 32% of people living in pain fear they will be judged
  • Women, people of colour and the LGBQ+ community are worst affected
  • Gen Z more likely to feel unheard than Baby Boomers

LONDON, Sept. 28, 2023 (GLOBE NEWSWIRE) — A new study of 18,097 people across 18 countries has discovered that society has grown less tolerant of people in pain, despite the effects of COVID-19 boosting global health awareness.

The fifth edition of the Haleon Pain Index (HPI)[1], conducted by consumer health company Haleon, suggests that attitudes towards pain in post-pandemic society are now more judgemental and less tolerant, with half (49%) of those in pain feeling stigmatised and a third (32%) fearing they will be judged about their pain.

The global index has been exploring the real impact pain has on people’s lives for almost a decade. This year’s study has found that, since the first edition in 2014, the social and emotional impact of pain has grown by nearly 25%, with stigma and social isolation arising from everyday pain increasing worldwide. 42% of people questioned said they regularly experience loneliness when in pain. Feelings of serious loneliness emerged globally, with 38% of people in mainland China, 33% in Australia and 32% in the UK reporting this. This coincides with warnings about the public health impacts of loneliness and social isolation issued by the World Health Organisation[4] and the Loneliness Epidemic[5] pointed out in spring 2023.

Dr Linda Papadopoulos, Psychologist and Author, commented: “Everyday pain is a health issue that can easily be dismissed or trivialised. Many don’t realise its effects can be much worse than the symptoms themselves. The result of loneliness and mental health impact caused by lack of empathy and being treated differently is only worsening. As a society, we need to improve empathy and understanding in a world that is continuing to harden to these issues.”

The HPI discovered that people who already experience bias, discrimination, and exclusion in society are the worst affected by these hardening views on pain.

  • 58% of women said their pain had been treated differently, not believed or discriminated versus 49% of men. This is highest amongst women in India (74%), Kingdom of Saudi Arabia (KSA) (74%), Brazil (74%), and mainland China (61%).
  • 59% of people of colour said their pain had been treated differently, not believed or discriminated versus 48% of white people. This is highest in Brazil (71%), Poland (64%) and the USA (64%), whilst this is true for 60% in the UK.
  • 44% of LGBQ+ people feared that others will make assumptions about them and their pain, compared to 32% of heterosexuals. This is highest in India (61%), USA (54%), Canada (49%) and Australia (48%).

The study also revealed a sharp generational divide in the way people experience pain, suggesting that younger patients struggle most with making their pain known and accessing treatment:

  • 70% of Gen Z said their pain had been treated differently, not believed or discriminated, compared to 40% of Baby Boomers. This is highest in India (80%), the USA (79%) and for 74% of UK respondents.
  • 45% of Gen Z said being in pain was too much of a taboo for them to speak out, compared to 35% of Boomers.

While the older generation find it easier to express their pain and access treatment, they are the most marginalised when it comes to accessing health-related information online. 45% of 75–84-year-olds said they struggle to access this online because they do not feel confident navigating the internet, compared with 33% overall.

Respondents agreed on the need for a more personalised and compassionate view of pain. More than two thirds (68%) of people said more empathy to address bias and exclusion would make a real difference to their experience of pain. Meanwhile, 69% said they wished doctors and 62% wished pharmacists were better trained on how individual pain is for different patients.

Lisa Jennings, Head of Global Over the Counter Category at Haleon, said: “While pain is a universal human experience, resulting in loneliness and stigma for many, its impact varies considerably between social groups, with the most marginalised amongst the worst affected. Our ambition is to break down the barriers to achieving better everyday health for everyone – irrespective of age, race, ethnicity, gender, sexual orientation, disability and other factors. The HPI shows that we can lessen the social and emotional impact of pain by shifting perceptions and conversations around pain management. That’s why we’re taking action through several programs such as our #ListenToPain initiative which is being rolled out to health professionals across the globe.”

Haleon’s #ListenToPain programme supports health professionals to improve communication with patients and have a focused discussion on pain tailored to the individual. #ListentoPain includes five profiles that describe people with different attitudes and behaviours towards pain management that help health professionals customize their approach with their patients. With continuity of care, truly understanding how pain may change over time means pain management strategies can be evolved and be more effective in the long term.

Media Contacts

For more information on the HPI, or interview requests please contact:

Nina.bass@edelman.com

Amy.barker@edelman.com

For information on Haleon please contact:

gemma.x.thomas@haleon.com

Notes to Editors

About the Haleon Pain Index study

The Haleon Pain Index (HPI) is a proprietary, globally representative, longitudinal social study conducted by Edelman Data x Intelligence (DXI). The study is designed to give a voice to those experiencing pain and assess the evolving state of pain. The study captures the perceived impact of pain on individuals’ everyday lives, their health, their feelings, emotions, motivations and behaviours, putting the human experience at the centre. In its fifth edition, the study assesses health inclusivity barriers to effective pain treatment. The perceptions of over 18,000 respondents across 18 countries were captured as part of the fifth edition.

Markets tracked in HPI 5: Australia, Brazil, Canada, China, Colombia, France, Germany, India, Italy, KSA, Malaysia, Mexico, Poland, South Africa, Spain, Sweden, UK, USA.

The age groups are split into different generations:

  • Gen Z: those between 18-26 years old
  • Millennials: those between 27-42 years old
  • Gen X: those between 43-58 years old
  • Boomers 1*: those between 59-66 years old
  • Boomers 2*: those between 67-77 years old
  • Silent: those between 78-84 years old

1*For the first time, the Haleon Pain Index (HPI) is now capturing the voice of experts, GPs, Pharmacists, and Nurses, in 4 key markets: Australia, Germany, KSA and the USA. In this first edition, we’ve gathered insights from over 600 experts (150 per market*) through a 15-minute online bespoke survey, exploring their views on pain, their challenges as healthcare professionals and the role they can play in driving positive change.

2*In the USA, our interviews included a mix of physicians and nurses; in Australia and KSA, a mix of physicians and pharmacists, and in Germany, a combination of pharmacists and pharmacists’ assistants.

About Listen To Pain

#ListenToPain is a global initiative from Haleon to enable health professionals to maximise their time with patients and help them to better understand a patient’s pain experience — providing the sufferer with a treatment plan that is right for them. Located on Haleon Health Partner, a dedicated digital platform for health professionals, #ListenToPain includes a series of practical tools for better interactions, assessments, and outcomes. These tools and resources for pharmacists will help them understand their patients pain better and navigate conversations around pain management.

Further information and the full range of #ListentoPain resources can we found on www.haleonhealthpartner.com.

About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon’s product portfolio spans five major categories – Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands – such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum – are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.

1 Haleon. Pain Index. 2023. Data on file.
2 The Haleon Pain Index is formerly known as the Global Pain Index.
3 Russell, D, et al.,1978. Developing a measure of loneliness. Journal of Personality Assessment, 42, 290-294. Available: https://fetzer.org/sites/default/files/images/stories/pdf/selfmeasures/Self_Measures_for_Loneliness_and_Interpersonal_Problems_UCLA_LONELINESS.pdf. [2023, September 18].
4 World Health Organization (WHO). N.d. Social Isolation and Loneliness. Available: https://www.who.int/teams/social-determinants-of-health/demographic-change-and-healthy-ageing/social-isolation-and-loneliness [2023, September 18].
5 Centers for Disease Control and Prevention. 2023. Health Risks of Social Isolation and Loneliness. Available: https://www.cdc.gov/emotional-wellbeing/social-connectedness/loneliness.htm#:~:text=Social%20isolation%20and%20loneliness%20have,linked%20to%20increased%20risk%20for%3A&text=Heart%20disease%20and%20stroke.,Type%202%20diabetes. [2023, September 18].

GlobeNewswire Distribution ID 8929418

‫سمو ولي العهد يُطلق المخطط العام لمشروع قمم السودة

الرياض، المملكة العربية السعودية، 26 سبتمبر 2023:

أطلق صاحب السمو الملكي الأمير محمد بن سلمان بن عبد العزيز آل سعود، ولي العهد رئيس مجلس الوزراء رئيس مجلس إدارة شركة السودة للتطوير -حفظه الله-، المخطط العام لمشروع تطوير السودة وأجزاء من رجال ألمع تحت مسمى “قمم السودة”، الذي يهدف إلى تطوير وجهة جبلية سياحية فاخرة فوق أعلى قمة في المملكة العربية السعودية على ارتفاع يصل إلى 3015 متر عن سطح البحر، في بيئة طبيعية وثقافية فريدة من نوعها في منطقة عسير جنوب غرب السعودية بما يتماشى مع جهود صندوق الاستثمارات العامة في تمكين القطاعات الحيوية الواعدة، ودعم استراتيجية تطوير منطقة عسير “قمم وشيم”.

وأكد سمو ولي العهد رئيس مجلس إدارة شركة السودة للتطوير -حفظه الله-، أن قمم السودة ستعكس الوجه الجديد للسياحة الجبلية الفاخرة من خلال توفير تجربة معيشية غير مسبوقة، وسيساهم المشروع في تحقيق مستهدفات رؤية السعودية 2030 وتنمية القطاع السياحي والترفيهي، ودعم النمو الاقتصادي من خلال المساهمة في زيادة إجمالي الناتج المحلي التراكمي بأكثر من 29 مليار ريال سعودي، وتوفير آلاف الوظائف بشكل مباشر وغير مباشر.

وقال سمو ولي العهد: “يؤكد المخطط العام سعينا لتفعيل الجهود العالمية في الحفاظ على البيئة والثروات الطبيعية والتراثية وحفظها للأجيال القادمة، وبما يسهم في تنويع مصادر الدخل وبناء اقتصاد جاذب للاستثمارات الدولية والمحلية”.

وأضاف سموه: “سيُحدث مشروع قمم السودة إضافة نوعية للقطاع السياحي وإبراز الجانب الثقافي في المملكة العربية السعودية، وسيساهم في جعل المملكة وجهة سياحية عالمية، وسيكون لدى العالم فرصة لاستكشاف جمال قمم السودة والتعرّف على تراثها الفريد وثقافتها الأصيلة ومجتمعها المضياف، وخوض تجارب لا تُنسى في أحضان الطبيعة وعلى متن السحاب”.

وسيوفر مشروع قمم السودة خدمات الضيافة الفاخرة لمليوني زائر على مدار العام، كما سيعتمد المخطط العام في تصاميمه على الهوية العمرانية المحلية، حيث يضم 6 مناطق رئيسية تتمركز في مواقع مميزة، وهي: تَهْلَل، سَحَاب، سَبْرَة، جَرين، رجال، الصخرة الحمراء، تتنوع مرافقها بين الفنادق والمنتجعات الجبلية الفاخرة، والقصور والوحدات السكنية ذات الإطلالات الآسرة والمتاجر الفارهة، بالإضافة إلى نقاط الجذب الترفيهية والرياضية والثقافية، حيث سيتم تطوير 2700 غرفة فندقية، و 1336 وحدة سكنية، و 80 ألف متر مربع من المساحات التجارية، بحلول عام 2033 ، ويتكون المخطط العام لقمم السودة من 3 مراحل رئيسية، ومن المتوقع أن تكتمل أولى مراحله في عام 2027 ، حيث تتضمن المرحلة الأولى تطوير 940 غرفة فندقية و 391 وحدة سكنية و 32 ألف متر مربع من المساحات التجارية. 

تقع قمم السودة على مساحة كبيرة من الغابات والجبال التي تمتد لأكثر من 627 كم² مع مساحة بناء لا تتجاوز 1% منها، مما يعكس التزام شركة السودة للتطوير بحماية البيئة وتطبيق معايير الاستدامة، والمحافظة على الموارد الطبيعية وتنميتها في منطقة المشروع التي تضم السودة وأجزاء من رجال ألمع، بما يدعم جهود مبادرة السعودية الخضراء.

يذكر أن السودة للتطوير هي إحدى شركات صندوق الاستثمارات العامة، تهدف إلى تطوير وجهة جبلية سياحية فاخرة، والحفاظ على البيئة الطبيعية والموروث الثقافي الإنساني في منطقة المشروع.

عن السودة للتطوير

السودة للتطوير هي إحدى شركات صندوق الاستثمارات العامة، تعمل على تطوير وجهة جبلية سياحية فاخرة في السودة وأجزاء من رجال ألمع، بمنطقة عسير جنوب غرب المملكة العربية السعودية. بهدف الحفاظ على المناظر الطبيعية والاحتفاء بالتراث الثقافي الغني للمنطقة، مع جذب 2 مليون زائر سنوياً على مدار العام بحلول 2033.

لمزيد من المعلومات، تفضل بزيارة الموقع الإلكتروني لشركة السودة للتطوير  www.soudah.sa

أو يمكنك زيارة الموقع الرسمي لقمم السودة www.soudahpeaks.com

حسابات قمم السودة على مواقع التواصل الاجتماعي @SoudahPeaks 

وللتواصل مع إدارة العلاقات العامة والإعلام: Press@soudah.sa 

الاتصال:
محمد الشهري
البريد الإلكتروني: Press@soudah.sa

GlobeNewswire Distribution ID 300906398

10 areas of the aerospace industry to be disrupted by AI tools

DUBLIN, Ireland, Sept. 27, 2023 (GLOBE NEWSWIRE) — The use of AI in aviation goes beyond customer support chatbots and price comparison tools for travelers. While these applications will definitely stay and become ubiquitous, the real disruption will come from optimizing the “hard” areas of aviation – from revenue management to evaluating the likelihood of a strike. Chairman of Avia Solutions Group Gediminas Ziemelis shares his predictions regarding the areas where AI in aviation will make a massive difference.

  1. Unlocking true dynamic pricing. In the airline business, revenue management has never been an easy game, but the stakes are even higher in the post-COVID world. According to IATA, the average profit margin per passenger today is truly razor-thin – just $2.25, compared to double-digit numbers in 2019. AI can help improve the tough task of analyzing historical data and calculating the right price, taking into account the client’s location and a myriad of other factors. While larger airlines will probably opt for building their own solutions in-house, there’s already a growing number of carriers partnering with the likes of AirGain – an AI-driven predictive solution with a data lake covering 6 billion price points.
  2. Maintaining engine health. Predictive maintenance has been an integral part of MRO for quite some time now, with sensors helping airlines determine when and what needs to be fixed or replaced. Artificial Intelligence can use both real-time sensor data and predictive historical fault patterns to reduce downtime and overall costs of maintenance. A recent study conducted by the University of Maryland’s Center for Advanced Aviation System Development (CAASD) found that predictive maintenance can reduce aircraft operational costs by up to 20%. AI is already disrupting this field. For instance, Lufthansa Technik has leveled up aircraft upkeep with its AI-driven predictive maintenance systems. Their Condition Analytics solution employs machine learning algorithms to analyze sensor data from various aircraft components, predicting maintenance needs with remarkable precision. The creation of so-called “digital twins” – perfect virtual replicas that change their parameters according to the physical component’s wear – MRO technicians use digital twins for predictive maintenance and to detect anomalies by comparing real-world sensor data to the data generated by digital twins.
  3. Planning the most efficient route. According to IATA, airlines will spend $215 billion this year, accounting for around 28% of operating expenses, which can be reduced with more efficient route planning. Numerous variables (including air traffic congestion, quickly changing weather patterns, and fluctuating fuel costs) make route planning a complex and demanding task, which can either improve or damage a carrier’s bottom line, depending on how efficiently it is performed. AI-enabled platforms can accelerate decision-making for operators, helping them harness not just the power of historical data but also of predictive mechanisms that, together, generate an actionable and clear picture. One example of such a platform is Flyways, which uses scheduled and active flight data to map out flight routes that go through less-congested areas and bypass areas with adverse weather conditions. The solution has already been tested out by Alaska Airlines, saving the company 480,000 gallons of fuel and resulting in 4,600 fewer tons in carbon emissions over a six-month period. The results of such AI-operator collaboration are reflected not only in cost savings but also in helping businesses become more sustainable. Once such solutions become commonplace not just among airlines but also flight authorities around the world, we will look back at today and be surprised at how inefficient all of us were when planning routes.
  4. Predicting strikes. While strikes in aviation usually make headlines because of the disruption they have on travelers’ plans (especially around major holidays), the fact that airlines can lose tens if not hundreds of millions per strike is often overlooked. In 2022, for instance, SAS lost $145 million over a 15-day pilot strike. As AI can analyze not just technical but also sociological data, a model could be designed to help airlines predict a potential strike and be better prepared for potential negotiations. Models like this that can predict the probability of individual employees leaving their jobs have already been developed by IBM, producing 95% accuracy.
  5. Improving workflows in-flight. An AI can serve as a helper not just to the staff on the ground but also to the cabin crew. It is not just about making routine tasks easier – a properly trained tool can offer expert advice on managing the aircraft and making quick, informed decisions, especially when the pressure is on and quick decisions are vital. The wheels are already in motion to bring this vision to life, with Level 1 AI applications nearing certification, thanks to EASA’s Trustworthiness of Machine Learning based Systems guidelines established in April 2022.
  6. Helping pilots and crew maintain their mental health. Could an AI model have prevented the suicide-by-pilot disaster of Germanwings Flight 9525 that led to the death of 150 people? While this is an area of much speculation, specially designed regular staff screenings can help predict the likelihood of mental issues exacerbated by exposure to stressful events, such as circadian rhythm disruptions, instances of turbulence, and onboard emergencies. Another promising application, which is already being tested by the UK startup Blueskeye AI, is the use of facial sensing technology to identify fatigue in pilots. Today, fatigue is calculated based on the number of hours a pilot has flown, but in the future, this metric will be highly individualized.
  7. Predicting the probability of Airworthiness Directives. An Airworthiness Directive (AD) for either a part of the frame or the engine can ground a sizeable share of an airline’s fleet, especially one that is not diversified across different models. Knowing the likelihood of such a risk can massively help at different stages of fleet management – from fleet formation to maintenance. Much like AI-driven risk management software in banks and financial institutions, a similar solution could be deployed to calculate and mitigate AD risks.
  8. Improving in-house quality management processes. While no malfunction will ever rival the $20 billion bill that Boeing had to foot because of the crashes and subsequent grounding of the 737 MAX, a QA issue can still bankrupt a company. While quality assurance standards in aviation are already higher than in any other industry due to strict regulation of everything related to safety and security, AI can boost in-house quality assurance protocols within the realms of aviation manufacturing and airline management. At the manufacturing stage, a sophisticated computer vision system enhanced by manual checks can better pinpoint flaws in components. For airlines, an AI-enhanced Safety Management System (SMS) can take into account vast amounts of data from various sources, including performance, weather partners and maintenance information.
  9. Finding the best logistics solution for AOG situations. While every aircraft on ground (AOG) situation is unique, it can cost the airline anything from $10,000 to $150,000, not to mention reputational damage. Figuring out the puzzle of both finding the spare part needed and delivering it in hours, and not days, can be tricky, especially if the AOG situation happens far away from major hubs. An AI solution could help the company quickly locate and ship the part to the aircraft. At the same time, a predictive maintenance solution can help prepare for potential AOG events and make sure that there are always enough critical parts in stock.
  10. Determining insurance pricing. In the post-9/11 world, aviation insurance buyers globally are still encountering escalating prices and diminished availability when it comes to war risk coverage. An AI model can help airlines calculate the risks they are facing more precisely, helping them to understand their “war risk” exposure when they are making insurance-related decisions.

About Gediminas Ziemelis

Gediminas Ziemelis (born April 4, 1977) is an accomplished Lithuanian entrepreneur, business consultant, and the founder and current Chairman of the Board of Avia Solutions Group, the largest global ACMI (Aircraft, Crew, Maintenance, and Insurance) provider, operating a fleet of 196 aircraft. He was selected twice among the top 40 most talented young industry leaders by Aviation Week & Space Technology.

Gediminas is known for his cosmopolitan mindset and exceptional management skills, which have contributed to his success in various business fields. Over his 26-year-long career, Gediminas has founded more than 100 start-ups, 50% of which are still in operation, led companies through 4 successful IPO/SPO processes, and raised over 800 million euros in global public capital and bond markets.

In December 2022, Gediminas Ziemelis was listed as the richest Lithuanian by TOP Magazine, with estimated assets worth 1.68 billion euros.

Gediminas is the largest donator of Rimantas Kaukenas Support Group, a charity and support fund, that provides help to children with oncological diseases and their families. He is also the biggest shareholder in the leading basketball club Wolves.

Media contact: 
Silvija Jakiene 
Chief Communications Officer 
Avia Solutions Group 
silvija.jakiene@aviasg.com 
+370 671 22697

GlobeNewswire Distribution ID 1000841364

HRH Crown Prince launches Soudah Peaks’ masterplan

HRH Crown Prince launches Soudah Peaks’ masterplan

RIYADH, Saudi Arabia, Sept. 27, 2023 (GLOBE NEWSWIRE) — His Royal Highness Crown Prince Mohammed bin Salman bin Abdulaziz Al Saud, Prime Minister, and Chairman of Soudah Development has launched the masterplan to develop Soudah and parts of Rijal Almaa into Soudah Peaks – a luxury mountain tourism destination set 3,015 meters above sea level on Saudi Arabia’s highest peak. Situated within an extraordinary natural and cultural environment in the Aseer region (southwest Saudi Arabia), the project is a key part of the Public Investment Fund (PIF)’s efforts to diversify the economy by expanding vital industries such as tourism, hospitality, and entertainment, and supporting Aseer development strategy.

HRH Crown Prince Mohammed bin Salman, Chairman of Soudah Development’s Board of Directors, stated that Soudah Peaks represents a new era of luxury mountain tourism by providing an unprecedented living experience while preserving the natural environment, cultural, and heritage richness. It is strategically aligned with Vision 2030 goals of expanding tourism and entertainment, supporting economic growth, attracting investments, contributing more than SAR 29 billion to the Kingdom’s cumulative GDP, and creating thousands of direct and indirect job opportunities.

HRH said, “The masterplan reaffirms our commitment to global efforts in preserving the environment and natural resources for future generations and aims to contribute to diversifying national income sources and building a strong economy that attracts local and global investments.”

HRH added, “Soudah Peaks will be a significant addition to the tourism sector in Saudi Arabia and place the Kingdom on the global tourism map, whilst highlighting and celebrating the country’s rich culture and heritage. Visitors will have the opportunity to discover the beauty of Soudah Peaks, explore its rich culture and heritage, and experience the authentic hospitality of the local community. Soudah Peaks will offer unforgettable experiences amidst lush greenery, above the clouds.”

Soudah Peaks aims to offer high-end luxurious hospitality services to over two million visitors throughout the year by 2033. The masterplan is being designed to reflect the local traditional, and architectural styles, and will promote both the cultural and landscape heritage of the region. The destination will be home to 6 unique development zones: Tahlal, Sahab, Sabrah, Jareen, Rijal, and Red Rock. Each will offer a range of world-class facilities including hotels, luxury mountain resorts, residential chalets, villas, premium mansion sites, entertainment and commercial attractions, as well as outdoor attractions dedicated to sports, adventure, wellness and culture.

Soudah Development will deliver 2,700 hospitality keys, 1,336 residential units, and 80,000 square meters of commercial space for Soudah Peaks by 2033. The masterplan will be developed over three phases, with 940 hotel keys, 391 residential units, and 32,000 square meters of retail space expected to be completed in 2027, within Phase one.

Soudah Peaks is set across more than 627 square kilometers of awe-inspiring nature, with less than 1% of the land being acquired for building, reflecting Soudah Development’s commitment to protecting and preserving the environment, following best-in-class sustainability standards, and contributing to the efforts of the Saudi Green Initiative.

As a closed joint-stock company owned by PIF, Soudah Development aims to develop a unique luxury mountain tourism destination in Saudi Arabia, whilst preserving the natural environment and cultural heritage of the project area spread across Soudah and parts of Rijal Almaa.

About Soudah Development
Soudah Development is a closed joint-stock company fully owned by the Public Investment Fund (PIF) of Saudi Arabia. It has been established to drive the development of a luxury mountain tourism destination, covering Soudah and parts of Rijal Almaa, in the Aseer region in southwest Saudi Arabia. It aims to preserve the natural landscape and respect the rich cultural heritage of the region, whilst attracting 2 million visitors every year by 2033. Soudah Development was announced by HRH Crown Prince Mohammad bin Salman bin Abdulaziz Al Saud, Prime Minister, and Chairman of PIF, on February 24, 2021.

For more information, visit the links below:
Website: www.soudah.sa & www.soudahpeaks.com
Twitter, Instagram, LinkedIn, and Facebook: @Soudahpeaks
Or by email: press@soudah.sa

Source: NewsBeatWire

Contacts:

Mohammed A. Alshehri

Press@soudah.sa

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

HRH Crown Prince launches Soudah Peaks’ masterplan

GlobeNewswire Distribution ID 1000841357

Datacubed Health Launches eClinical Platform App in China, Ensuring Full Compliance and Accessibility

Datacubed Health and AppInChina Forge Strategic Partnership to Launch eClinical Platform in China

New York, New York, Sept. 26, 2023 (GLOBE NEWSWIRE) — Datacubed Health, a leading global provider of innovative solutions for patient engagement and data collection in clinical trials, is excited to announce the official launch of its eClinical platform app in China. This milestone achievement represents a significant step forward for Datacubed Health’s commitment to expanding its presence in the Chinese market.

As part of this strategic move, Datacubed Health has joined forces with AppInChina, a renowned leader in Android App Store publication, ensuring seamless deployment of the eClinical platform app in official Android stores across China and the Apple App Store. This partnership guarantees accessibility to a wide range of devices and ecosystems.

Kyle Hogan, President of Datacubed Health, emphasized the importance of this collaboration: “Our partnership with AppInChina has been instrumental in ensuring the smooth launch of our eClinical platform app in China. This strategic alliance allows us to reach a broader audience while maintaining compliance with local regulations, which is essential for our growth in this market.”

In preparation for this momentous launch, Datacubed Health has established a legal entity within China and acquired all necessary commercial and legal licenses and certificates. These crucial steps are a testament to Datacubed Health’s commitment to providing secure and regulated services within the Chinese market.

Brett Kleger, CEO of Datacubed Health, stated, “Our investment in establishing a legal presence and obtaining the requisite licenses underscores our dedication to operating ethically and responsibly in China. We are focused on delivering cutting-edge solutions while adhering to local regulations and standards.”

Moreover, Datacubed Health has undertaken comprehensive efforts to ensure full software compliance with Chinese regulations. The eClinical platform app for China has been meticulously customized to align with local requirements and has undergone rigorous testing by local quality assurance teams. This meticulous approach ensures the seamless functioning of the platform while adhering to Chinese network security requirements and restrictions.

Datacubed Health has also bolstered its presence in China by establishing a fully compliant and fault-tolerant Software as a Service (SaaS) infrastructure. The Datacubed China solution is now hosted in AWS Beijing, ensuring data security and reliability for users in the region.

With these key developments in operational, legal, and software compliance, Datacubed Health is well-prepared to provide unmatched support to clinical research efforts in China. The launch of the eClinical platform app represents a significant stride in bridging the gap between global research initiatives and the Chinese healthcare landscape.

In the words of CEO Brett Kleger: “We are thrilled to introduce Datacubed Health’s eClinical platform app to the Chinese market. Our partnership with AppInChina, legal entity establishment, and rigorous compliance efforts demonstrate our dedication to providing world-class services to our Chinese users. We look forward to empowering clinical research initiatives in China with our cutting-edge solutions.”

To learn more, we invite you to join us at Booth #24 at the 11th Annual Outsourcing in Clinical Trials Southern California 2023 from September 26-27 in San Diego, California, or visit our website at www.datacubed.com.

About Datacubed Health:

Datacubed Health is a pioneering eClinical technology company built from the ground up by industry veterans who wanted to create a better clinical trial experience for all stakeholders. Our solutions are all infused with neuroeconomic principles designed to be inclusive, drive compliance, and greatly improve retention. We strive to deliver the best experience for you and your patients through ease of use and flexible technology configurable to your needs. Our offerings include a Decentralized Trials Platform, eCOA/ePRO, Patient Engagement, eConsent, Medication Adherence, Televisits, and Geofencing. Learn more at www.datacubed.com.

Media Contact:
Heather Shea
Catalytic Agency for Datacubed Health
heather.shea@catalyticagency.com

Jillian Tygh
Datacubed Health
2672543997
jillian.tygh@datacubed.com

GlobeNewswire Distribution ID 8926943